Innovative developer of long-term oxygen therapy technologies selects clinivation WorldView as its most comprehensive, authoritative resource for building its medical product submissions and registrations worldwide.
Framingham, MA, January 18, 2007 – clinivation, Inc. announced today that Inogen has selected clinivation WorldView™ Online Regulatory Intelligence solution.
“We are pleased that Inogen has selected clinivation WorldView as their source for worldwide regulatory intelligence and procedures,” remarked Richard Morroney, R.A.C., C.Q.A., clinivation’s Vice President of Quality and Regulatory Solutions, “With information on >99% of the world markets, Inogen will be able to stay current on ever-changing regulations,” he continued.
Clinivation WorldView is your most comprehensive, authoritative, and up-to-date resource for building all of your medical device submissions and registrations worldwide. Clinivation WorldView also interoperates with clinivation Global™ enterprise software to make building and tracking medical device submissions and registrations easier than ever before.
Inogen has also selected clinivation’s Regulatory Solutions team to accelerate the device-specific regulatory research process for marketing hurdles related to their oxygen concentrator.
Clinivation’s Regulatory Practice delivers expertise, experience, and an outstanding track record.
Inogen is an emerging leader in the innovative manufacture of respiratory home health care equipment. Inogen’s first product, the Inogen One portable oxygen concentrator, has been widely lauded by industry experts as a breakthrough in both technology and design.
Inogen is committed to revolutionizing oxygen therapy, developing innovative, cost effective respiratory home health care equipment that improves quality of life for patients and operational efficiency for providers.
For further information, visit www.inogen.net.